Arrowstreet Capital’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-77,034
| Closed | -$478K | – | 1309 |
|
|
2022
Q1 | $478K | Sell |
77,034
-112,513
| -59% | -$698K | ﹤0.01% | 1033 |
|
|
2021
Q4 | $1.34M | Sell |
189,547
-28,072
| -13% | -$198K | ﹤0.01% | 1101 |
|
|
2021
Q3 | $1.52M | Sell |
217,619
-116,820
| -35% | -$815K | ﹤0.01% | 1199 |
|
|
2021
Q2 | $2.79M | Buy |
334,439
+139,469
| +72% | +$1.16M | ﹤0.01% | 1248 |
|
|
2021
Q1 | $1.07M | Sell |
194,970
-4,400
| -2% | -$24K | ﹤0.01% | 1765 |
|
|
2020
Q4 | $855K | Hold |
199,370
| – | – | ﹤0.01% | 1870 |
|
|
2020
Q3 | $600K | Buy |
199,370
+136,856
| +219% | +$412K | ﹤0.01% | 1973 |
|
|
2020
Q2 | $194K | Buy |
62,514
+41,214
| +193% | +$128K | ﹤0.01% | 2175 |
|
|
2020
Q1 | $47K | Hold |
21,300
| – | – | ﹤0.01% | 1822 |
|
|
2019
Q4 | $65K | Hold |
21,300
| – | – | ﹤0.01% | 1687 |
|
|
2019
Q3 | $65K | Buy |
+21,300
| New | +$65K | ﹤0.01% | 1518 |
|
|
2019
Q2 | – | Sell |
-31,492
| Closed | -$136K | – | 1509 |
|
|
2019
Q1 | $136K | Sell |
31,492
-8,011
| -20% | -$34.6K | ﹤0.01% | 1668 |
|
|
2018
Q4 | $126K | Hold |
39,503
| – | – | ﹤0.01% | 1288 |
|
|
2018
Q3 | $207K | Buy |
39,503
+14,300
| +57% | +$74.9K | ﹤0.01% | 1018 |
|
|
2018
Q2 | $135K | Hold |
25,203
| – | – | ﹤0.01% | 1024 |
|
|
2018
Q1 | $126K | Buy |
+25,203
| New | +$126K | ﹤0.01% | 1078 |
|